PSI Expands International Clinical Trial Presence to South Africa


Company News Release

Today, PSI CRO, a full-service contract research organization, announced their expansion into South Africa.

South Africa is a multi-cultural nation with a population of ~50 million people.  It has a long history of conducting clinical trials.  As such, there exists a strong infrastructure to support all needed activities including regulatory oversight and experienced researchers.  Data generated from South African trials receives international acceptance. Expert opinion leaders work in South Africa, providing a high standard of medical care.  Therefore, patients who have received state-of-the-art therapy, in addition to treatment-naïve patients, may be recruited for clinical trials.  PSI will expand its access to all African countries from the strong base in Pretoria. PSI’s current experience in South Africa stretches across the areas of oncology, CNS, urology, diabetes and other therapeutic areas.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.